National Institute of Diabetes and Digestive and Kidney Diseases, USA
Jürgen Wess, PhD, is the Chief of the Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA. He received his Ph.D. in Pharmacology from the Goethe University in Frankfurt/Main (Germany) and subsequently worked as a Postdoctoral Fellow at the National Institute of Mental Health (NIMH) and the National Institute of Neurological Disorders and Stroke (NINDS), NIH, Bethesda, Maryland, USA. Dr. Wess is a pharmacologist with primary interest in the general area of G protein-coupled receptors (GPCRs). During the past two decades, Dr. Wess’ lab has generated and analyzed a very large number GPCR mutant mouse lines. The ultimate goal of Dr. Wess’ research is to identify novel GPCR signaling pathways that can serve as new drug targets, in particular for the treatment of disorders of glucose and energy homeostasis.